Cytokinetics
Price & Volume
Stats
See more52W Range | $44.49-$84.05 |
Market Cap | $5.7B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $3.2M |
Revenue Growth (YoY) | 22.5% |
Gross Profit (12 Mos) | -$327.5M |
Diluted EPS | -$5.38 |
News
See moreYahoo Finance • 9 days ago
Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction
Yahoo Finance • 6 months ago
Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Yahoo Finance • 8 months ago
Insider Sale: VP, Chief Accounting Officer Robert Wong Sells Shares of Cytokinetics Inc (CYTK)
Yahoo Finance • 9 months ago
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Robert I. Blum |
CFO | Mr. Sung H. Lee |
Address | 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 423 |
